Altimmune, Inc. Stock Agreements
7 Contracts & Agreements
- Form of Restricted Stock Agreement under the Altimmune, Inc. 2018 Inducement Grant Plan (Filed With SEC on December 3, 2018)
- Form of Non-Qualified Stock Option Agreement under the Altimmune, Inc. 2018 Inducement Grant Plan (Filed With SEC on December 3, 2018)
- 15,656 Series B Convertible Preferred Shares Warrants to Purchase 2,345,427 Common Shares ALTIMMUNE, INC. Preferred Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 17, 2017)
- NONQUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVEPLAN * * * * * (Filed With SEC on May 8, 2017)
- PHARMATHENE, INC. Up to $15,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 25, 2013)
- FORM OF RESTRICTED STOCK AGREEMENT (Filed With SEC on May 11, 2011)
- PHARMATHENE,INC. 4,300,000Shares of Common Stock UnderwritingAgreement (Filed With SEC on November 1, 2010)
